Daniel E. Spratt

Active 2010–2025

Also published as
Daniel E Spratt
226
Papers
21,449
Citations
75
h-index
212
i10-index

Citations

Citations per year for Daniel E. Spratt1998: 1 citations2003: 1 citations2004: 1 citations2005: 1 citations2006: 3 citations2007: 1 citations2010: 3 citations2011: 6 citations2012: 12 citations2013: 19 citations2014: 31 citations2015: 45 citations2016: 86 citations2017: 90 citations2018: 88 citations2019: 598 citations2020: 858 citations2021: 1,087 citations2022: 884 citations2023: 798 citations2024: 1,456 citations2025: 662 citations2026: 28 citations1999–2002: no citations, so these years are not shown2008–2009: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,634 citing papers, 26.2% of this breakdownChina: 788 citing papers, 7.8% of this breakdownCanada: 661 citing papers, 6.6% of this breakdownUnited Kingdom: 656 citing papers, 6.5% of this breakdownItaly: 564 citing papers, 5.6% of this breakdownGermany: 472 citing papers, 4.7% of this breakdownFrance: 357 citing papers, 3.6% of this breakdownAustralia: 343 citing papers, 3.4% of this breakdownNetherlands: 306 citing papers, 3% of this breakdownSwitzerland: 280 citing papers, 2.8% of this breakdownSpain: 268 citing papers, 2.7% of this breakdownJapan: 213 citing papers, 2.1% of this breakdown
0%26.2%Other 25%

Fields

  • Medicine72.7%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Physics and Astronomy1.9%
  • Computer Science1.5%
  • Immunology and Microbiology1.4%
  • Engineering0.8%
  • Other3.1%

Topics

  • Prostate Cancer Treatment and Research15.6%
  • Prostate Cancer Diagnosis and Treatment12.3%
  • Advanced Radiotherapy Techniques3.7%
  • Cancer Genomics and Diagnostics2.4%
  • Cancer, Lipids, and Metabolism2.3%
  • Radiopharmaceutical Chemistry and Applications2.1%
  • Other61.6%

Coauthors

All papers

Open in search
  1. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Dorothy A. Shead, Jenna Snedeker, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2023 cited by 571

  2. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Chou, Haolong Li, Rajdeep Das, Hui Li, Ruhollah Moussavi-Baygi, Hani Goodarzi, Luke A. Gilbert, Primo N. Lara, Christopher P. Evans, Theodore C. Goldstein, Joshua M. Stuart, Scott A. Tomlins, Daniel E. Spratt, R. Keira Cheetham, Donavan T. Cheng, Kyle Kai‐How Farh, Julian Gehring, Jörg Hakenberg, Arnold Liao, Philip G. Febbo, John Shon, Brad Sickler, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, Felix Y. Feng - Cell 2018 cited by 759

  3. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandy Liu, Alexander G. Balogh, Pamela D. Randolph-Jackson, David L. Schwartz, Michael R. Girvigian, Naoyuki G. Saito, Adam Raben, Rachel A. Rabinovitch, Khalil Katato, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad - npj Digital Medicine, npj Digit. Medicine 2022 cited by 197

  4. The DNA methylation landscape of advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, M. Yvonne Kim, Lawrence Fong, Daniel E. Spratt, Todd M. Morgan, Rohit Bose, Franklin W. Huang, Hui Li, Lisa N. Chesner, Tanushree Shenoy, Hani Goodarzi, Irfan A. Asangani, Shahneen Sandhu, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phillip G. Febbo, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Wilbert Zwart, J Costello, Jianhua Luo, Scott A. Tomlins, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Luke A. Gilbert, Paul C. Boutros, Kyle Kai‐How Farh, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, David A. Quigley, Felix Y. Feng - Nature Genetics 2020 cited by 353

  5. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2021 cited by 530

  6. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157

  7. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2019 cited by 1,573

  8. Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 567

  9. Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - NEJM Evidence 2023 cited by 120

  10. Prostate Cancer, Version 3.2024

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Jenna Snedeker, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2024 cited by 272

  11. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Ryan A. Berardi, Dorothy A. Shead, Deborah A. Freedman-Cass - 2022 cited by 172

  12. Racial/Ethnic Disparities in Genomic Sequencing

    Authors: , , , , , , - JAMA Oncology 2016 cited by 361

  13. Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 409

  14. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew L. Freedman, X. Shirley Liu, Myles Brown, Henry W. Long, David P. Labbé - Nature Communications 2022 cited by 156

  15. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)

    Authors: , , , , , , , , , , , , , , , , - European Urology 2020 cited by 303

  16. Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report

    Authors: , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2021 cited by 220

  17. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 cited by 208

  18. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Y Jia, Jorge A Garcia, Daniel E Spratt - The Lancet Oncology 2022 cited by 181

  19. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118

  20. Artificial intelligence applications in prostate cancer

    Authors: , , , , , , , , , , , - Prostate Cancer and Prostatic Diseases 2023 cited by 71

  21. International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery

    Authors: , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2012 cited by 611

  22. PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 436

  23. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report

    Authors: , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 355

  24. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorelei A. Mucci, Jorge E. Chavarro, Massimo Loda, Myles Brown - Nature Communications 2019 cited by 182